Close



Jul 16, 2021 09:30AM
Dec 3, 2018 02:33PM
Dec 3, 2018 02:32PM
Nov 1, 2018 10:23AM
Nov 1, 2018 10:23AM
Sep 24, 2018 06:32AM
Sep 24, 2018 06:30AM Alexion Announces Successful Phase 3 PREVENT Study of Soliris® (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Aug 20, 2018 06:32AM
Aug 20, 2018 06:30AM
Jun 28, 2018 06:33AM
Jun 28, 2018 06:30AM
Jun 19, 2018 06:31AM
Jun 19, 2018 06:30AM
Jun 14, 2018 07:32AM Alexion (ALXN)Says Selection of Positive Phase 3 Clinical Data for ALXN1210 in Patients with PNH for Late-Breaking Oral Presentation at EHA
Jun 14, 2018 07:30AM
Mar 15, 2018 06:31AM
Mar 15, 2018 06:30AM
Dec 26, 2017 06:31AM
Dec 26, 2017 06:30AM
Dec 11, 2017 10:03AM
Dec 11, 2017 10:00AM Results of Phase 1b/2 Dose Regimen Optimization Studies for ALXN1210 in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Presented at American Society of Hematology (ASH) Meeting
Nov 6, 2017 06:31AM
Nov 6, 2017 06:30AM
Nov 1, 2017 09:26AM
Nov 1, 2017 09:25AM
Oct 24, 2017 06:10AM
Oct 23, 2017 08:05PM
Sep 14, 2017 05:37AM Alexion Pharma (ALXN) Announces Interim Analysis from Phase 3 Open-Label Extension Study Shows Sustained Benefits of Soliris (Eculizumab) Treatment
Sep 13, 2017 06:00PM
Aug 21, 2017 09:26AM
Aug 21, 2017 09:25AM
Aug 15, 2017 04:10PM
Aug 15, 2017 04:05PM
Jun 23, 2017 08:04AM
Jun 23, 2017 08:00AM Alexion Receives Positive CHMP Opinion for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG) in the European Union
Mar 22, 2017 04:08PM
Mar 22, 2017 04:05PM
Mar 8, 2017 06:31AM
Mar 8, 2017 06:30AM
Jan 9, 2017 06:33AM
Jan 9, 2017 06:30AM
Nov 17, 2016 05:33PM Alexion Pharma (ALXN) Says Data from Global aHUS Registry Shows Reduced Risk with Soliris
Nov 17, 2016 05:32PM
Oct 27, 2016 06:32AM
Oct 27, 2016 06:31AM
Jul 7, 2016 08:31AM
Jul 7, 2016 08:30AM
Jun 10, 2016 02:30AM
Jun 1, 2016 04:07PM Alexion Pharma (ALXN) Granted Ophand Drug Status in Europe for ALXN1210
Jun 1, 2016 04:05PM

13,127 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All